G01N 2333/96472
Aspartic endopeptidases
Official title: Aspartic endopeptidases (3.4.23)
G01N2333/96472 (Aspartic endopeptidases) appears on 78 US grants and 100 published applications in this corpus.
Search patents in G01N- Granted patents
- 78
- Published applications
- 100
- Assignees
- 87
- Inventors
- 260
- Latest grant
- 6 May 2025
Filings by year
| Year | Granted patents | Published applications |
|---|---|---|
| 1976 | 1 | 0 |
| 1977 | 0 | 0 |
| 1978 | 0 | 0 |
| 1979 | 0 | 0 |
| 1980 | 0 | 0 |
| 1981 | 0 | 0 |
| 1982 | 0 | 0 |
| 1983 | 0 | 0 |
| 1984 | 0 | 0 |
| 1985 | 0 | 0 |
| 1986 | 0 | 0 |
| 1987 | 0 | 0 |
| 1988 | 1 | 0 |
| 1989 | 2 | 0 |
| 1990 | 0 | 0 |
| 1991 | 1 | 0 |
| 1992 | 1 | 0 |
| 1993 | 0 | 0 |
| 1994 | 1 | 0 |
| 1995 | 0 | 0 |
| 1996 | 0 | 0 |
| 1997 | 3 | 0 |
| 1998 | 0 | 0 |
| 1999 | 4 | 0 |
| 2000 | 3 | 0 |
| 2001 | 1 | 3 |
| 2002 | 5 | 6 |
| 2003 | 1 | 7 |
| 2004 | 12 | 6 |
| 2005 | 7 | 8 |
| 2006 | 2 | 1 |
| 2007 | 1 | 4 |
| 2008 | 6 | 3 |
| 2009 | 1 | 4 |
| 2010 | 5 | 5 |
| 2011 | 0 | 3 |
| 2012 | 0 | 2 |
| 2013 | 2 | 2 |
| 2014 | 0 | 5 |
| 2015 | 1 | 5 |
| 2016 | 4 | 4 |
| 2017 | 4 | 7 |
| 2018 | 0 | 2 |
| 2019 | 0 | 3 |
| 2020 | 2 | 3 |
| 2021 | 3 | 3 |
| 2022 | 0 | 3 |
| 2023 | 1 | 3 |
| 2024 | 1 | 3 |
| 2025 | 2 | 0 |
| 2026 | 0 | 5 |
By publication year. Applications have been published since 2001. 2026 runs to 8 Oct.
Subgroups
Granted patents
Recent patents
- LC-MS/MS-based methods for characterizing proteins6 May 2025US 12,292,447 B2Commonwealth Scientific and Industrial Research Organisation
- Vasopressin formulations for use in treatment of hypotension7 Jan 2025US 12,186,362 B2Par Pharmaceutical, Inc.
- Modulating biomarkers such as SPP to increase tumor immunity and improve the efficacy of cancer immunotherapy30 Jul 2024US 12,050,219 B2Dana-Farber Cancer Institute, Inc.
- Antibodies against BACE1 and use thereof for neural disease immunotherapy5 Sep 2023US 11,746,160 B2Adimab, LLC
- Method for measurement of peptidic degradation products of a proteolytic cascade in blood samples3 Aug 2021US 11,079,398 B2Attoquant Diagnostics GmbH
- Biomarkers for huntington disease stratification, methods and uses thereof13 Aug 2026US 2026/0235626 A1
- Method and device for predicting significant gastric aspiration and lung transplant outcome30 Jul 2026US 2026/0219272 A1University Health Network
- Methods for spatial analysis using templated ligation30 Apr 2026US 2026/0117298 A110x Genomics, Inc.
- Vasopressin Formulations for Use in Treatment Of Hypotension12 Feb 2026US 2026/0041729 A1Par Pharmaceutical, Inc.
- Biomarkers8 Jan 2026US 2026/0009802 A1Oxford University Innovation Limited
Most cited
By later US patents
- Method of catalyzing chemical reactions46US 4,888,281 AIgen, Inc. · 1989
- Catalytic antibodies as chemical sensors42US 6,846,654 B1IGEN International, Inc. · 2005
- Alzheimer's disease secretase, APP substrates therefor, and uses thereof32US 6,420,534 B1Pharmacia & Upjohn Company · 2002
- Alzheimer's disease secretase, APP substrates therefor, and uses therefor29US 6,440,698 B12002
- Renin inhibitory peptides containing an N-alkyl-histidine moiety23US 4,880,781 AThe Upjohn Company · 1989